If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
88.00    1.90 (2.21%)
Bid:
88.90
Ask:
90.00
Spread: 1.10 (1.237%)
Market Cap: £144.27m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Disposal

12 Mar 2010 07:00

RNS Number : 4786I
Yule Catto & Co PLC
12 March 2010
 



12 March 2010

Yule Catto & Co plc

 

Disposal of Revertex Finewaters Sdn Bhd

Yule Catto & Co plc ("the Group"), an international producer of specialty chemicals, is pleased to announce that its joint venture subsidiary, Revertex (Malaysia) Sdn Bhd, has exchanged conditional contracts with H. B. Fuller Company for the sale of Revertex Finewaters Sdn Bhd ("Revertex Finewaters").

 

The consideration to be received by the Group for its 63% effective interest in Revertex Finewaters is Malaysian Ringgit 55.6 million (£11 million) representing an 8 x multiple of EBITDA in 2009. The consideration will be paid in full in cash at completion. The proceeds of the sale will be used to reduce the Group's borrowings.

 

The completion of the sale is conditional on approval from the Malaysian regulatory authorities.

 

Revertex Finewaters is a leading Malaysian manufacturer and supplier of adhesives for industrial use in the local market and exports to other parts of South East Asia. In the twelve months to 31 December 2009 it had sales of MR 62.4 million (£13 million), an operating profit of MR 11 million (£2 million) and gross assets of MR 37.2 million (£7 million).

 

The Revertex Finewaters' management team, led by Dr Kuek Heng Thong, will continue to run the business.

 

Adrian Whitfield, Chief Executive, commented:

 

"We are pleased to have secured the sale of this non-core business to a strategic global adhesives manufacturer which allows us to focus on the development of our polymer manufacturing activities in Asia. We will continue to supply key raw materials to Revertex Finewaters from our other existing facility in Malaysia under a long term supply contract."

 

- Ends -

 

Enquiries:

 

Yule Catto & Co plc

Tel: 01279 442791

Adrian Whitfield, Chief Executive

David Blackwood, Finance Director

Hogarth

Tel: 020 7357 9477

John Olsen

Andrew Jaques

Ian Payne

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISLFFVFVEILLII
Date   Source Headline
6th Mar 20258:32 amRNSDirector Declaration
13th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 202510:30 amRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSWinter trading statement
2nd Jan 20259:00 amRNSDirectorate Change
31st Oct 20247:00 amRNSTrading statement - Autumn 2024
17th Oct 20244:01 pmRNSHolding(s) in Company
14th Oct 20241:51 pmRNSHolding(s) in Company
27th Sep 202412:46 pmRNSHolding(s) in Company
19th Sep 20241:01 pmRNSHolding(s) in Company
13th Aug 20247:00 amRNSInterim results
18th Jul 202412:53 pmRNSChair succession and other board changes
17th May 20248:20 amRNSPost Stabilisation Notice
9th May 20242:29 pmRNSResults of AGM
9th May 20247:00 amRNSTrading Statement - Spring 2024
1st May 20247:00 amRNSDivestment of Compounds completed
25th Apr 20244:30 pmRNSDirector/PDMR Shareholding
25th Apr 20244:20 pmRNSDirector/PDMR Shareholding
17th Apr 202410:43 amRNSTender offer results
15th Apr 20247:00 amRNSDivestment of Compounds
12th Apr 20247:00 amRNSPricing of senior notes
9th Apr 20243:47 pmRNSPre Stabilisation Notice
9th Apr 20248:09 amRNSNotice of tender offer
9th Apr 20248:09 amRNSProposed offering of senior notes
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:10 pmRNSAnnual Financial Report and Notice of AGM
12th Mar 20247:00 amRNSFinal Results
30th Jan 20247:00 amRNSTrading Statement
17th Jan 20242:58 pmRNSExternal Appointment
15th Nov 20237:00 amRNSTrading statement - Autumn 2023
3rd Nov 20232:54 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:58 pmRNSDirector/PDMR Shareholding
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20233:13 pmRNSHolding(s) in Company - CORRECTION
16th Oct 202312:06 pmRNSHolding(s) in Company
16th Oct 202312:03 pmRNSHolding(s) in Company
16th Oct 202311:57 amRNSHolding(s) in Company
16th Oct 20237:00 amRNSTotal Voting Rights
16th Oct 20237:00 amRNSPDMR and PCA Notification
13th Oct 20234:18 pmRNSHolding(s) in Company
13th Oct 202310:48 amRNSHolding(s) in Company
13th Oct 20237:00 amRNSResult of rump placing
12th Oct 20234:36 pmRNSResult of Equity Issue
12th Oct 202310:09 amRNSHolding(s) in Company
11th Oct 20239:39 amRNSHolding(s) in Company
11th Oct 20237:00 amRNSPDMR PCA Notification
10th Oct 20233:04 pmRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.